Burkina Faso vs Guinea: Population requiring preventive chemotherapy for schistosomiasis
Burkina Faso
4.46 million
in 2024
Guinea
4.21 million
in 2024
Burkina Faso rank
19th
Guinea rank
20th
Population requiring preventive chemotherapy for schistosomiasis over time
- Burkina Faso
- Guinea
How they compare
Burkina Faso currently reports 4.46 million against 4.21 million in Guinea, a difference of 254,190.
That makes Burkina Faso's figure about 1.1 times Guinea's.
The two have swapped places 4 times across 15 shared years of data; in 2010 it was Burkina Faso ahead.
Burkina Faso ranks 19th and Guinea ranks 20th of 52 countries.
Across the 2 decades both report, Burkina Faso averaged higher in 1 and Guinea in 1.
Head to head by decade
| Decade | Burkina Faso | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.88 million | 2.98 million | 893,029 | Burkina Faso |
| 2020s | 3.48 million | 4.42 million | 940,884 | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Burkina Faso or Guinea?
- Burkina Faso, at 4.46 million against 4.21 million in Guinea as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Burkina Faso and Guinea?
- 254,190, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Guinea?
- 15 years are reported by both, from 2010 to 2024.
- How do Burkina Faso and Guinea rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Burkina Faso ranks 19th and Guinea ranks 20th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.